HK1103439A1 - Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment - Google Patents
Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatmentInfo
- Publication number
- HK1103439A1 HK1103439A1 HK07107590.2A HK07107590A HK1103439A1 HK 1103439 A1 HK1103439 A1 HK 1103439A1 HK 07107590 A HK07107590 A HK 07107590A HK 1103439 A1 HK1103439 A1 HK 1103439A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cancer cells
- treatment
- neu
- detection
- elevated levels
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
- G01N2333/4706—Regulators; Modulating activity stimulating, promoting or activating activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61633204P | 2004-10-06 | 2004-10-06 | |
PCT/US2005/035894 WO2006041959A2 (fr) | 2004-10-06 | 2005-10-06 | Detection de taux eleves de proteine her-2/neu sur des cellules cancereuses circulantes et traitement associe |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1103439A1 true HK1103439A1 (en) | 2007-12-21 |
Family
ID=36148887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07107590.2A HK1103439A1 (en) | 2004-10-06 | 2007-07-16 | Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment |
Country Status (10)
Country | Link |
---|---|
US (2) | US20080261243A1 (fr) |
EP (1) | EP1797431B1 (fr) |
JP (1) | JP4798801B2 (fr) |
CN (1) | CN101036055B (fr) |
AT (1) | ATE497165T1 (fr) |
CA (1) | CA2582713A1 (fr) |
DE (1) | DE602005026143D1 (fr) |
HK (1) | HK1103439A1 (fr) |
MX (1) | MX2007004079A (fr) |
WO (1) | WO2006041959A2 (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005034628B4 (de) * | 2005-07-19 | 2007-08-23 | Epigenomics Ag | Verfahren zur Untersuchung von Cytosin-Methylierungen in DNA |
EP1803822A1 (fr) * | 2005-12-30 | 2007-07-04 | Adnagen AG | Procédé pour la caractérisation individuelle de molécules cibles thérapeutiques, et leur utilisation |
JP5025724B2 (ja) | 2006-04-18 | 2012-09-12 | ウェルスタット バイオロジクス コーポレイション | 循環腫瘍性細胞からのタンパク質の検出 |
US20090291920A1 (en) * | 2006-04-18 | 2009-11-26 | Wellstat Biologics Corporation | Detection of steroid receptors on circulating carcinoma cells and treatment |
DE602007008080D1 (de) * | 2006-04-18 | 2010-09-09 | Wellstat Biologics Corp | Detektion von zirkulierenden endothelzellen |
US20080200342A1 (en) * | 2007-02-15 | 2008-08-21 | Rao Rupa S | Device, Array, And Methods For Disease Detection And Analysis |
MX2009011228A (es) * | 2007-04-19 | 2009-11-02 | Wellstat Biologics Corp | Deteccion de niveles elevados de la proteina her-2/neu de celulas cancerosas circulantes no aisladas y tratamiento. |
KR100972618B1 (ko) * | 2007-10-19 | 2010-07-27 | 국립암센터 | 허셉틴을 이용한 유방암 진단 키트, 조성물 및 이들을이용하여 허셉틴 민감성 her2 과발현 세포를 검출하는방법 |
JP5040597B2 (ja) * | 2007-11-06 | 2012-10-03 | 日本電気株式会社 | 評価システム、評価方法および評価プログラム |
EP2133433A1 (fr) * | 2008-06-09 | 2009-12-16 | Centre Georges François Leclerc | Procédé de prédiction de la réactivité à un traitement avec un anticorps anti-HER2 |
EP2362783A2 (fr) | 2008-10-31 | 2011-09-07 | Biogen Idec MA Inc. | Molécules ciblant light et leurs utilisations |
WO2010070117A1 (fr) * | 2008-12-18 | 2010-06-24 | Universite Libre De Bruxelles | Procédé de traitement par administration de composés actifs ciblés anti-her2 à des patients atteints d'un cancer du sein précoce et d'une tumeur primaire her2 négative |
CN101880650B (zh) * | 2009-05-04 | 2013-01-16 | 卢焕梅 | 一种从外周血中快速提取循环的非血缘性有核细胞的组合物和试剂盒及其应用 |
AU2011274789B2 (en) * | 2010-07-07 | 2014-04-10 | The Regents Of The University Of Michigan | Diagnosis and treatment of breast cancer |
FR2976294B1 (fr) | 2011-06-10 | 2018-02-16 | Universite De Nice Sophia Antipolis | Methode de prediction de la reponse a un traitement avec un agent bloquant her2 |
CN102830228B (zh) * | 2011-06-15 | 2015-01-21 | 格诺思博生物科技(上海)有限公司 | 定量分析循环肿瘤细胞的试剂及试剂盒 |
CN104122394A (zh) * | 2013-04-23 | 2014-10-29 | 北京豪迈生物工程有限公司 | 人表皮生长因子受体2(Her-2)定量测定试剂盒及其检测方法 |
CN104561246B (zh) * | 2013-10-18 | 2018-06-15 | 深圳先进技术研究院 | 血液中循环癌细胞的检测信号放大的方法与试剂盒 |
CN104568923A (zh) * | 2014-12-01 | 2015-04-29 | 浙江省肿瘤医院 | 电化学发光检测外周血循环肿瘤细胞抗原的方法及试剂盒 |
CN104458710B (zh) * | 2014-12-09 | 2017-11-14 | 山东省海盟生化科技有限公司 | 肿瘤早期高通量电化学发光检测方法的构建 |
CN106932583A (zh) * | 2015-12-29 | 2017-07-07 | 北京大成生物工程有限公司 | 人表皮生长因子受体Her-2/neu定量检测试剂盒及其制备方法与应用 |
CN106226374B (zh) * | 2016-08-18 | 2018-10-16 | 中南大学 | 一种人类表皮生长因子受体-2浓度的检测方法 |
CN106319069B (zh) * | 2016-09-28 | 2020-02-14 | 河南乾坤科技有限公司 | 一种精确测定病源细胞的试剂盒及其应用 |
CN111257310B (zh) * | 2020-03-10 | 2023-05-02 | 莆田学院附属医院(莆田市第二医院) | 一种用于癌细胞识别的电致化学发光传感器的制备方法 |
CN117074692B (zh) * | 2023-08-15 | 2024-04-09 | 复旦大学附属华山医院 | 一种关于脑脊液中肿瘤细胞her2抗原表达生物信息的识别方法 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6451225B1 (en) * | 1986-04-30 | 2002-09-17 | Igen International, Inc. | Electrochemiluminescent reaction utilizing amine-derived reductant |
US5401638A (en) * | 1986-06-04 | 1995-03-28 | Oncogene Science, Inc. | Detection and quantification of neu related proteins in the biological fluids of humans |
US4968603A (en) * | 1986-12-31 | 1990-11-06 | The Regents Of The University Of California | Determination of status in neoplastic disease |
US5720937A (en) * | 1988-01-12 | 1998-02-24 | Genentech, Inc. | In vivo tumor detection assay |
WO1989006692A1 (fr) * | 1988-01-12 | 1989-07-27 | Genentech, Inc. | Procede de traitement de cellules tumorales par inhibition de la fonction receptrice du facteur de croissance |
US6448091B1 (en) * | 1988-11-03 | 2002-09-10 | Igen International, Inc. | Method and apparatus for improved luminescence assays using particle concentration chemiluminescence detection |
US5801005A (en) * | 1993-03-17 | 1998-09-01 | University Of Washington | Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
US6884357B2 (en) * | 1995-02-21 | 2005-04-26 | Iqbal Waheed Siddiqi | Apparatus and method for processing magnetic particles |
US5783404A (en) * | 1995-04-13 | 1998-07-21 | Amgen Inc. | Methods and compositions for determining HER-2/neu expression using monoclonal antibodies |
ES2285713T3 (es) * | 1995-06-07 | 2007-11-16 | Bioveris Corporation | Enzimoinmunoanalisis electroquimioluminiscente. |
US6117985A (en) * | 1995-06-16 | 2000-09-12 | Stemcell Technologies Inc. | Antibody compositions for preparing enriched cell preparations |
US6190870B1 (en) * | 1995-08-28 | 2001-02-20 | Amcell Corporation | Efficient enrichment and detection of disseminated tumor cells |
US6297062B1 (en) * | 1996-03-07 | 2001-10-02 | Bio-Magnetics Ltd. | Separation by magnetic particles |
US6890426B2 (en) * | 1996-06-07 | 2005-05-10 | Immunivest Corporation | Magnetic separation apparatus and methods |
WO1999041613A1 (fr) * | 1998-02-12 | 1999-08-19 | Immunivest | Methodes et reactifs pour l'isolation rapide et efficace de cellules cancereuses circulantes |
US20020172987A1 (en) * | 1998-02-12 | 2002-11-21 | Terstappen Leon W.M.M. | Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
AU2876900A (en) * | 1999-02-10 | 2000-08-29 | Cell Works Inc. | Class characterization of circulating cancer cells isolated from body fluids andmethods of use |
US6300143B1 (en) * | 1999-03-01 | 2001-10-09 | Idec Pharmaceuticals Corporation | Electrochemiluminescent assays for eukaryotic cells |
US6969615B2 (en) * | 1999-07-26 | 2005-11-29 | 20/20 Genesystems, Inc. | Methods, devices, arrays and kits for detecting and analyzing biomolecules |
JP2003523178A (ja) * | 1999-11-15 | 2003-08-05 | ユニバーシティ・オブ・サザン・カリフォルニア | 治療又は診断のための成分の攻撃目標を設定したデリバリー |
US7537938B2 (en) * | 2000-04-28 | 2009-05-26 | Monogram Biosciences, Inc. | Biomarker detection in circulating cells |
CA2438112A1 (fr) * | 2001-02-16 | 2003-08-07 | Immunivest Corporation | Methodes et reactifs destines a l'isolement rapide et efficace de cellules cancereuses circulantes |
JP3313107B2 (ja) * | 2001-03-22 | 2002-08-12 | バイエル コーポレイション | ヒトの生物学的流体中のneu関連タンパク質の検出及び定量 |
ATE479490T1 (de) * | 2001-10-11 | 2010-09-15 | Aviva Biosciences Corp | Verfahren zum trennen von seltenen zellen von fluidproben |
CA2490758C (fr) * | 2002-07-15 | 2014-09-23 | Genentech, Inc. | Forme posologique de l'anticorps monoclonal humanise recombinant 2c4 |
GB0512429D0 (en) * | 2005-06-17 | 2005-07-27 | Smithkline Beecham Corp | Novel compound |
EP1816477A1 (fr) * | 2006-02-06 | 2007-08-08 | F. Hoffmann-la Roche AG | Utilisation de peptides natriurétiques et niveaux du facteur de croissance du placenta pour la stratification de risque de personnes choisies pour l'essai de contraintes cardiaques |
DE602007008080D1 (de) * | 2006-04-18 | 2010-09-09 | Wellstat Biologics Corp | Detektion von zirkulierenden endothelzellen |
US20090291920A1 (en) * | 2006-04-18 | 2009-11-26 | Wellstat Biologics Corporation | Detection of steroid receptors on circulating carcinoma cells and treatment |
JP5025724B2 (ja) * | 2006-04-18 | 2012-09-12 | ウェルスタット バイオロジクス コーポレイション | 循環腫瘍性細胞からのタンパク質の検出 |
-
2005
- 2005-10-06 CA CA002582713A patent/CA2582713A1/fr not_active Abandoned
- 2005-10-06 EP EP05807568A patent/EP1797431B1/fr not_active Not-in-force
- 2005-10-06 JP JP2007535785A patent/JP4798801B2/ja not_active Expired - Fee Related
- 2005-10-06 CN CN2005800339861A patent/CN101036055B/zh not_active Expired - Fee Related
- 2005-10-06 DE DE602005026143T patent/DE602005026143D1/de active Active
- 2005-10-06 WO PCT/US2005/035894 patent/WO2006041959A2/fr active Application Filing
- 2005-10-06 US US11/575,811 patent/US20080261243A1/en not_active Abandoned
- 2005-10-06 MX MX2007004079A patent/MX2007004079A/es active IP Right Grant
- 2005-10-06 AT AT05807568T patent/ATE497165T1/de not_active IP Right Cessation
-
2007
- 2007-07-16 HK HK07107590.2A patent/HK1103439A1/xx not_active IP Right Cessation
-
2010
- 2010-02-18 US US12/708,159 patent/US20110070598A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1797431A4 (fr) | 2008-07-09 |
WO2006041959A3 (fr) | 2006-06-15 |
WO2006041959A8 (fr) | 2008-01-31 |
JP2008517253A (ja) | 2008-05-22 |
US20080261243A1 (en) | 2008-10-23 |
EP1797431B1 (fr) | 2011-01-26 |
DE602005026143D1 (de) | 2011-03-10 |
MX2007004079A (es) | 2007-06-15 |
US20110070598A1 (en) | 2011-03-24 |
CN101036055A (zh) | 2007-09-12 |
ATE497165T1 (de) | 2011-02-15 |
CN101036055B (zh) | 2011-06-29 |
EP1797431A2 (fr) | 2007-06-20 |
JP4798801B2 (ja) | 2011-10-19 |
WO2006041959A2 (fr) | 2006-04-20 |
CA2582713A1 (fr) | 2006-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1103439A1 (en) | Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment | |
MX2009011228A (es) | Deteccion de niveles elevados de la proteina her-2/neu de celulas cancerosas circulantes no aisladas y tratamiento. | |
Gao et al. | Circulating cell-free DNA for cancer early detection | |
Chen et al. | Indoxyl sulfate enhance the hypermethylation of klotho and promote the process of vascular calcification in chronic kidney disease | |
Romiti et al. | Circulating tumor cells count predicts survival in colorectal cancer patients | |
CA3011087A1 (fr) | Procedes de production d'agents therapeutiques anticancereux specifiques aux patients et procedes de traitement associes | |
TW200626900A (en) | Wnt proteins and detection and treatment of cancer | |
NO20050775L (no) | Fremgangsmater for identifisering av tumorer som responderer pa behandling med anti-ErbB2-antistoffer | |
TW200626899A (en) | Frizzled proteins and detection and treatment of cancer | |
NZ616755A (en) | Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy | |
WO2009077864A3 (fr) | Compositions et procédés de détection d'anticorps tiab | |
WO2006025028A3 (fr) | Nouvelle methode de classification des globules sanguins servant de base a des activites therapeutiques et preventives sur mesure | |
WO2016201450A3 (fr) | Traitement et diagnostic du cancer | |
WO2006034328A3 (fr) | Proteines wnt et detection et traitement du cancer | |
WO2005113831A3 (fr) | Biomarqueurs pour la sclerose en plaques et procedes d'utilisation correspondants | |
WO2008140774A3 (fr) | Procédés de diagnostic et de traitement du cancer de la prostate et du cancer du poumon | |
WO2007081790A3 (fr) | Procedes de diagnostic et de traitement du cancer de la prostate | |
Mortensen et al. | Quality of life in patients with multiple myeloma: a qualitative study | |
WO2019066617A3 (fr) | Anticorps anti-c-met et ses utilisations | |
WO2019066620A3 (fr) | Anticorps anti-c-met et ses utilisations | |
MX2022003719A (es) | Anticuerpos anti-il-27 y sus usos. | |
WO2014146035A3 (fr) | Compositions et procédés de diagnostic d'un cancer | |
WO2006029052A8 (fr) | Procedes d'evaluation d'atherosclerose | |
Koguchi et al. | 760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab | |
Kurata et al. | Nestin expression as an independent indicator of poor prognosis for patients with anaplastic thyroid cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20141006 |